Siegel R, Miller K, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;64(1):5–29. doi:10.3322/caac.21254.
Article
Google Scholar
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107.
Article
PubMed
Google Scholar
Chaturvedi A, Anderson W, Lortet-Tieulent J, Curado M, Ferlay J, Franceschi S, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550–9. doi:10.1200/JCO.2013.50.3870.
Article
PubMed
PubMed Central
Google Scholar
Simard EP, Torre LA, Jemal A. International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol. 2014;50(5):387–403. doi:10.1016/j.oraloncology.2014.01.016.
Article
PubMed
Google Scholar
Ang K, Harris J, Wheeler R, Weber R, Rosenthal D, Nguyen-Tan P, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35. doi:10.1056/NEJMoa0912217.
Article
CAS
PubMed
PubMed Central
Google Scholar
Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24(36):5630–6. doi:10.1200/JCO.2005.04.6136.
Article
CAS
PubMed
Google Scholar
Ringash J. Survivorship and quality of life in head and neck cancer. J Clin Oncol. 2015;33(29):3322–7. doi:10.1200/jco.2015.61.4115.
Article
PubMed
Google Scholar
Adelstein D, Li Y, Adams G, Wagner H, Kish J, Ensley J, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21(1):92–8.
Article
PubMed
Google Scholar
Forastiere A, Goepfert H, Maor M, Pajak T, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–8. doi:10.1056/NEJMoa031317.
Article
CAS
PubMed
Google Scholar
List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K, et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol. 1999;17(3):1020.
CAS
PubMed
Google Scholar
García-Peris P, Lozano MA, Velasco C, de La Cuerda C, Iriondo T, Bretón I, et al. Prospective study of resting energy expenditure changes in head and neck cancer patients treated with chemoradiotherapy measured by indirect calorimetry. Nutrition. 2005;21(11–12):1107–12. http://dx.doi.org/10.1016/j.nut.2005.03.006.
Article
PubMed
Google Scholar
Lonbro S, Petersen GB, Andersen JR, Johansen J. Prediction of critical weight loss during radiation treatment in head and neck cancer patients is dependent on BMI. Support Care Cancer. 2016;24(5):2101–9. doi:10.1007/s00520-015-2999-8.
Article
PubMed
Google Scholar
Mick R, Vokes EE, Weichselbaum RR, Panje WR. Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy. Otolaryngol Head Neck Surg. 1991;105(1):62–73.
CAS
PubMed
Google Scholar
Ghadjar P, Hayoz S, Zimmermann F, Bodis S, Kaul D, Badakhshi H, et al. Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94). Radiat Oncol. 2015;10(1):21.
Article
PubMed
PubMed Central
Google Scholar
Silver HJ, Dietrich MS, Murphy BA. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck. 2007;29(10):893–900. doi:10.1002/hed.20607.
Article
PubMed
Google Scholar
Nourissat A, Bairati I, Samson E, Fortin A, Gelinas M, Nabid A, et al. Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer. 2010;116(9):2275–83. doi:10.1002/cncr.25041.
PubMed
Google Scholar
Couch ME, Dittus K, Toth MJ, Willis MS, Guttridge DC, George JR, et al. Cancer cachexia update in head and neck cancer: pathophysiology and treatment. Head Neck. 2015;37(7):1057–72. doi:10.1002/hed.23696.
Article
PubMed
Google Scholar
Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009;73(2):410–5. http://dx.doi.org/10.1016/j.ijrobp.2008.04.048.
Article
PubMed
Google Scholar
Langmore S, Krisciunas GP, Miloro KV, Evans SR, Cheng DM. Does PEG use cause dysphagia in head and neck cancer patients? Dysphagia. 2011;27(2):251–9. doi:10.1007/s00455-011-9360-2.
Article
PubMed
PubMed Central
Google Scholar
Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma. Cancer. 2001;91(9):1785–90. doi:10.1002/1097-0142(20010501)91:9<1785::AID-CNCR1197>3.0.CO;2-1.
Article
CAS
PubMed
Google Scholar
Couch M, Lai V, Cannon T, Guttridge D, Zanation A, George J et al. Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment. Head Neck. 2007;29. doi:10.1002/hed.20447.
Lenk K, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 2010;1. doi:10.1007/s13539-010-0007-1.
Carmeli E, Coleman R, Reznick AZ. The biochemistry of aging muscle. Exp Gerontol. 2002;37(4):477–89. http://dx.doi.org/10.1016/S0531-5565(01)00220-0.
Article
CAS
PubMed
Google Scholar
Doherty TJ. Invited Review: aging and sarcopenia. J Appl Physiol. 2003;95(4):1717–27. doi:10.1152/japplphysiol.00347.2003.
Article
CAS
PubMed
Google Scholar
Tzankoff SP, Norris AH. Effect of muscle mass decrease on age-related BMR changes. J Appl Physiol. 1977;43(6):1001–6.
CAS
PubMed
Google Scholar
Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism. 1970;19(9):653–63.
Article
CAS
PubMed
Google Scholar
Mijnarends DM, Meijers JM, Halfens RJ, ter Borg S, Luiking YC, Verlaan S, et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc. 2013;14(3):170–8. doi:10.1016/j.jamda.2012.10.009.
Article
PubMed
Google Scholar
Prado CMM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15(8):2920–6. doi:10.1158/1078-0432.ccr-08-2242.
Article
CAS
PubMed
Google Scholar
McMillan DC, Watson WS, Preston T, McArdle CS. Lean body mass changes in cancer patients with weight loss. Clin Nutr. 2000;19(6):403–6. http://dx.doi.org/10.1054/clnu.2000.0136.
Article
CAS
PubMed
Google Scholar
Kadar L, Albertsson M, Areberg J, Landberg T, Mattsson S. The prognostic value of body protein in patients with lung cancer. Ann N Y Acad Sci. 2000;904:584–91.
Article
CAS
PubMed
Google Scholar
Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, den Braver NR, Berkhof J, Langius JA, et al. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol. 2016;34(12):1339–44.
Article
PubMed
Google Scholar
Grossberg AJ, Chamchod S, Fuller CD, Mohamed AS, Heukelom J, Eichelberger H, et al. Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma. JAMA Oncol. 2016;2(6):782–9. doi:10.1001/jamaoncol.2015.6339.
Article
PubMed
Google Scholar
Baxi SS Jones L, Eaton A, Gandelman S, Halpenny D, Jackson J, et al. Changes in body composition and prognostic importance of sarcopenia in patients receiving CTRT for oropharyngeal cancer. J Clin Oncol. 2016;34(supplement):abstr 6077.
Google Scholar
Collins J, Noble S, Chester J, Coles B, Byrne A. The assessment and impact of sarcopenia in lung cancer: a systematic review. BMJ Open. 2014;46. doi:10.1136/bmjopen-2013-003697.
Pereira CT, Barrow RE, Sterns AM, Hawkins HK, Kimbrough CW, Jeschke MG, et al. Age-dependent differences in survival after severe burns: a unicentric review of 1,674 patients and 179 autopsies over 15 years. J Am Coll Surg. 2006;202(3):536–48. doi:10.1016/j.jamcollsurg.2005.11.002.
Article
PubMed
Google Scholar
Evans WJ. What is sarcopenia? J Gerontol A Biol Sci Med Sci. 1995;50(Spec No):5–8.
Article
PubMed
Google Scholar
Fulster S, Tacke M, Sandek A, Ebner N, Tschope C, Doehner W, et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J. 2013;34(7):512–9. doi:10.1093/eurheartj/ehs381.
Article
PubMed
Google Scholar
Sharma A, Méndez E, Yueh B, Lohavanichbutr P, Houck J, Doody DR, et al. Human papillomavirus–positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories. Otolaryngol Head Neck Surg. 2012;146(5):739–45.
Article
PubMed
PubMed Central
Google Scholar
Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889–96.
Article
PubMed
Google Scholar
Fleg JL, Lakatta EG. Role of muscle loss in the age-associated reduction in VO2 max. J Appl Physiol. 1988;65(3):1147–51.
CAS
PubMed
Google Scholar
Blair SN, Kampert JB, Kohl HW, Barlow CE, Macera CA, Paffenbarger RS, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. 1996;276(3):205–10.
Article
CAS
PubMed
Google Scholar
Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol. 2003;15(8):443–50. doi:10.1016/S0936-6555(03)00155-9.
Article
CAS
Google Scholar
Langius JA, Zandbergen MC, Eerenstein SE, van Tulder MW, Leemans CR, Kramer MH, et al. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review. Clin Nutr. 2013;32(5):671–8. doi:10.1016/j.clnu.2013.06.012.
Article
PubMed
Google Scholar
Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck. 2005;27(8):659–68. doi:10.1002/hed.20221.
Article
PubMed
Google Scholar
Rabinovitch R, Grant B, Berkey BA, Raben D, Ang KK, Fu KK, et al. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03. Head Neck. 2006;28(4):287–96. doi:10.1002/hed.20335.
Article
PubMed
Google Scholar
Dechaphunkul T, Martin L, Alberda C, Olson K, Baracos V, Gramlich L. Malnutrition assessment in patients with cancers of the head and neck: A call to action and consensus. Crit Rev Oncol Hematol. 2013;88(2):459–76. doi:10.1016/j.critrevonc.2013.06.003.
Wigmore SJ, Fearon KC, Maingay JP, Ross JA. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci. 1997;92(2):215–21.
Article
CAS
PubMed
Google Scholar
Price SA, Tisdale MJ. Mechanism of inhibition of a tumor lipid-mobilizing factor by eicosapentaenoic acid. Cancer Res. 1998;58(21):4827–31.
CAS
PubMed
Google Scholar
Weed HG, Ferguson ML, Gaff RL, Hustead DS, Nelson JL, Voss AC. Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein‐and energy‐dense nutritional supplement containing eicosapentaenoic acid. Head Neck. 2011;33(7):1027–33.
Article
PubMed
Google Scholar
Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007(1):CD004597. doi:10.1002/14651858.CD004597.pub2.
Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17(4):519–31. http://dx.doi.org/10.1016/S1470-2045(15)00558-6.
Article
CAS
PubMed
Google Scholar
Schmitz KH, Ahmed RL, Hannan PJ, Yee D. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomark Prev. 2005;14. doi:10.1158/1055-9965.epi-04-0736.
Mock V, Pickett M, Ropka ME, Muscari Lin E, Stewart KJ, Rhodes VA et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract. 2001;9. doi:10.1046/j.1523-5394.2001.009003119.x.
Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003;21(9):1660–8.
Article
PubMed
Google Scholar
Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2010;4. doi:10.1007/s11764-009-0110-5.
Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21(9):1653–9. doi:10.1200/JCO.2003.09.534.
Article
PubMed
Google Scholar
Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28(2):340–7.
Article
PubMed
Google Scholar
Rogers L, Courneya K, Robbins KT, Malone J, Seiz A, Koch L, et al. Physical activity and quality of life in head and neck cancer survivors. Support Care Cancer. 2006;14(10):1012–9. doi:10.1007/s00520-006-0044-7.
Article
PubMed
Google Scholar
Samuel SR, Maiya GA, Babu AS, Vidyasagar MS. Effect of exercise training on functional capacity & quality of life in head & neck cancer patients receiving chemoradiotherapy. Indian J Med Res. 2013;137(3):515–20.
PubMed
PubMed Central
Google Scholar
Rogers LQ, Anton PM, Fogleman A, Hopkins–Price P, Verhulst S, Rao K, et al. Pilot, randomized trial of resistance exercise during radiation therapy for head and neck cancer. Head Neck. 2013;35(8):1178–88. doi:10.1002/hed.23118.
Article
PubMed
Google Scholar
Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB. Causes of death in long-term survivors of head and neck cancer. Cancer. 2014;120(10):1507–13. doi:10.1002/cncr.28588.
Article
PubMed
PubMed Central
Google Scholar